Non-alcoholic fatty liver disease (NAFLD) is by far the most prevalent form of liver disease
worldwide. It's also the leading cause of liver-related hospitalizations and deaths …

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease associated with the
pathological accumulation of lipids inside hepatocytes. Untreated NAFL can progress to non …

Bacterial overgrowth in the small intestine (SIBO) is a pathological growth of the intestinal
microbiota in the small intestine that causes clinical symptoms and can lead to digestive and …

Summary Background & Aims Non‐alcoholic fatty liver disease (NAFLD) can develop in
individuals who are not overweight. Whether lean persons with NAFLD have lower mortality …

Background Metabolic-associated fatty liver disease (MAFLD) encompasses diverse
disease groups with potentially heterogeneous clinical outcomes. We investigated the risk of …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, with
an estimated prevalence of 25% globally. NAFLD is closely associated with metabolic …

Metabolic (dysfunction) associated fatty liver disease (MAFLD), previously known as non-
alcoholic fatty liver disease, is the most common cause of chronic liver disease worldwide …

Backgrounds Nonalcoholic fatty liver disease (NAFLD) is linked to obesity and metabolic
syndrome conditions. However, a subset of NAFLD patients express a normal or low body …

Non-alcoholic fatty liver disease (NAFLD) represents the hepatic expression of the metabolic
syndrome and is the most prevalent liver disease. NAFLD is associated with liver-related …

Non-alcoholic fatty liver disease occurring in non-obese subjects (the so-called non-obese
NAFLD) is a highly prevalent but neglected liver condition, which is closely associated with …